Jamabo M, Bentley S, Macucule-Tinga P, Tembo P, Edkins A, Boshoff A
Front Mol Biosci. 2022; 9:947078.
PMID: 36213128
PMC: 9538636.
DOI: 10.3389/fmolb.2022.947078.
Shahinas D, Pillai D
Adv Exp Med Biol. 2021; 1340:125-139.
PMID: 34569023
DOI: 10.1007/978-3-030-78397-6_5.
Bassanini I, Parapini S, Ferrandi E, Gabriele E, Basilico N, Taramelli D
Biomolecules. 2021; 11(1).
PMID: 33466300
PMC: 7824787.
DOI: 10.3390/biom11010056.
Prasanna P, Upadhyay A
Infect Immun. 2020; 89(2).
PMID: 33139381
PMC: 7822131.
DOI: 10.1128/IAI.00559-20.
Batista F, Ramos Jr S, Tassone G, Leitao A, Montanari C, Botta M
J Enzyme Inhib Med Chem. 2020; 35(1):639-649.
PMID: 32048531
PMC: 7034072.
DOI: 10.1080/14756366.2020.1726342.
The Hsp70/J-protein machinery of the African trypanosome, Trypanosoma brucei.
Bentley S, Jamabo M, Boshoff A
Cell Stress Chaperones. 2018; 24(1):125-148.
PMID: 30506377
PMC: 6363631.
DOI: 10.1007/s12192-018-0950-x.
MAPK1 of Leishmania donovani interacts and phosphorylates HSP70 and HSP90 subunits of foldosome complex.
Kaur P, Garg M, Hombach-Barrigah A, Clos J, Goyal N
Sci Rep. 2017; 7(1):10202.
PMID: 28860596
PMC: 5579238.
DOI: 10.1038/s41598-017-09725-w.
Increased Abundance of Proteins Involved in Resistance to Oxidative and Nitrosative Stress at the Last Stages of Growth and Development of Leishmania amazonensis Promastigotes Revealed by Proteome Analysis.
Alcolea P, Alonso A, Garcia-Tabares F, Mena M, Ciordia S, Larraga V
PLoS One. 2016; 11(10):e0164344.
PMID: 27776144
PMC: 5077082.
DOI: 10.1371/journal.pone.0164344.
Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
Santos D, Petersen A, Celes F, Borges V, Veras P, de Oliveira C
PLoS Negl Trop Dis. 2014; 8(10):e3275.
PMID: 25340794
PMC: 4207694.
DOI: 10.1371/journal.pntd.0003275.
Immunolocalization of anti-hsf1 to the acetabular glands of infectious schistosomes suggests a non-transcriptional function for this transcriptional activator.
Ishida K, Varrecchia M, Knudsen G, Jolly E
PLoS Negl Trop Dis. 2014; 8(7):e3051.
PMID: 25078989
PMC: 4117452.
DOI: 10.1371/journal.pntd.0003051.
Exploring the Trypanosoma brucei Hsp83 potential as a target for structure guided drug design.
Pizarro J, Hills T, Senisterra G, Wernimont A, MacKenzie C, Norcross N
PLoS Negl Trop Dis. 2013; 7(10):e2492.
PMID: 24147171
PMC: 3798429.
DOI: 10.1371/journal.pntd.0002492.
Anti-malarial activity of geldanamycin derivatives in mice infected with Plasmodium yoelii.
Mout R, Xu Z, Wolf A, Davisson V, Jarori G
Malar J. 2012; 11:54.
PMID: 22361388
PMC: 3361485.
DOI: 10.1186/1475-2875-11-54.
Apoptosis caused by Hsp90 inhibitor geldanamycin in Leishmania donovani during promastigote-to-amastigote transformation stage.
Li Q, Zhou Y, Yao C, Ma X, Wang L, Xu W
Parasitol Res. 2009; 105(6):1539-48.
PMID: 19690889
DOI: 10.1007/s00436-009-1582-y.
Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83.
Adriano M, Vergnes B, Poncet J, Mathieu-Daude F, Cordeiro da Silva A, Ouaissi A
Parasitol Res. 2006; 100(4):811-8.
PMID: 17096142
DOI: 10.1007/s00436-006-0352-3.
Inhibition of HSP90 in Trypanosoma cruzi induces a stress response but no stage differentiation.
Graefe S, Wiesgigl M, Gaworski I, MacDonald A, Clos J
Eukaryot Cell. 2002; 1(6):936-43.
PMID: 12477794
PMC: 138760.
DOI: 10.1128/EC.1.6.936-943.2002.